Exact Sciences – Oncotype MAP™ Pan-Cancer Tissue Test
Rick Baehner, MD, Chief Medical Officer of Precision Oncology at Exact Sciences discusses the Oncotype MAP™ Pan-Cancer Tissue test for patients with a...
5240 articles
Rick Baehner, MD, Chief Medical Officer of Precision Oncology at Exact Sciences discusses the Oncotype MAP™ Pan-Cancer Tissue test for patients with a...
Pritesh Shah, Chief Commercial Officer of device maker Novocure® discusses Tumor Treating Fields, a cap-like device that aims electric fields at cancer...
Justin Odegaard, VP of Clinical Development at Guardant Health discusses a new study published in "Nature Medicine" (Oct 2020) which finds that the Guar...
Rohit Dhall, MD, Associate Professor of Neurology and Director of Neurodegenerative Disorders at the University of Arkansas discusses essential tremors ...
Robert Provenzano, Associate Clinical Professor of Medicine at Wayne State University School of Medicine in Detroit, Michigan, discusses chronic kidney ...
Saad Usmani, a specialist in hematology and oncology at Levine Cancer Institute in Charlotte, NC, discusses multiple myeloma and relapsed refractory mul...
David Spetzler, President and Chief Scientific Officer of Caris Life Sciences, discusses the company's launch of CODEai™(Comprehensive Oncology Data E...
Susan, a woman living with an NTRK gene fusion, a rare genomic driver that drove her thyroid cancer shares her unique cancer journey and how she benefit
Scott Sigman, Founder and CMO of OrthoLazer and Team Physician at UMASS Lowell, discusses the publication of a second case report demonstrating positive...
Jim Palma, Executive Director at TargetCancer Foundation discusses a new clinical trial called TRACK (TargetRare Cancer Knowledge).